Icon

AVOPEF (NDA220200)- (100MG/5ML (20MG/ML))

ETOPOSIDE AVYXA HOLDINGS
100MG/5ML (20MG/ML)
No Yes
Expired Expired
None None
None No
AVOPEF is a topoisomerase inhibitor indicated, in combination with other chemotherapy and/or immunotherapy, for the treatment of adult patients with: • Refractory testicular cancer • Small cell lung cancer
0 0 0
Total Other Developers None
Drugs with Suitability No
100MG/5ML (20MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.